Crossmark

Low-Dose Endothelial Monocyte-Activating Polypeptide-II Increases Blood–Tumor Barrier Permeability by Activating the RhoA/ROCK/PI3K Signaling Pathway

Crossref DOI link: https://doi.org/10.1007/s12031-015-0668-5

Published Online: 2015-10-31

Published Print: 2016-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Zhen

Liu, Xiao-bai

Liu, Yun-hui

Xue, Yi-xue

Liu, Jing

Teng, Hao

Xi, Zhuo

Yao, Yi-long
Funding

Funding for this research was provided by:

the Natural Science Foundation of China (No. 81372682, Nos. 81172197 and 81372484), Nos. 81171131 and 81272564)

Shenyang Science and Technology Plan Projects (No. F15-199-1-54)

Outstanding Scientific Fund of Shengjing Hospital (No. 201304)
License Information

Text and Data Mining valid from 2015-10-31